FDA & Regulatory Town Hall
Direct dialogue with CDRH leadership on the 510(k) reform agenda, combination products, and the new De Novo pathway guidance released this year.
View track →The Medtech Industry's Defining Gathering · Sept 29 – Oct 1, 2014 · Chicago
Where medical technology meets the next decade of patient care.
Three days. 2,500+ executives, clinicians, regulators, and investors shaping the future of diagnostics, digital health, and connected care. AdvaMed 2014 convenes the people building what comes next.
By the Numbers
The gathering that moves the medtech industry forward.
For more than four decades, AdvaMed's annual conference has been the place where the medical technology sector aligns on policy, capital, and clinical progress.
2,500+
Industry executives, clinicians & investors across 40 countries
120+
Speakers from FDA, CMS, leading OEMs and academic medical centers
48
Curated sessions across regulatory, clinical, and commercial tracks
$1.4T
In represented medtech market capitalization on the exhibit floor
What to Expect
Six tracks. One pulse. The signal that defines the year ahead.
From the FDA Town Hall to the Investor Forum, every program strand is engineered to deliver actionable intelligence to the people building medical technology.
Investor & Capital Forum
Two days of curated 1:1 meetings, growth-stage pitch sessions, and a strategic outlook on medtech M&A from leading healthcare bankers and PE firms.
View track →Digital Health & Connected Devices
From wearable diagnostics to hospital-grade remote monitoring — the data infrastructure, cybersecurity, and reimbursement paths that make connected care real.
View track →Diagnostics & Personalized Medicine
Companion diagnostics, liquid biopsy, and the payer landscape that decides which molecular tests reach the clinic — and at what price.
View track →Global Market Access
CE Mark evolution under the new EU Medical Device Regulations, BRIC market entry strategy, and comparative reimbursement case studies from five health systems.
View track →Workforce & Leadership
Building diverse engineering and commercial teams, navigating the device tax, and the leadership competencies that separate category leaders from the rest.
View track →
Headline Voices
Three speakers setting the agenda for medtech in 2015.
Plenary keynotes from operators, regulators, and clinicians defining the post-reform medtech economy.
JM
Dr. Jeffrey M. Jonas
CEO, SAGE Therapeutics
Former Group President, Shire Pharmaceuticals
"From molecule to market in 36 months — what CNS drug-device combinations taught us about neuro-innovation."
EW
Esther A. Wynn, JD, MPH
Partner, FDA & Life Sciences Practice
King & Spalding LLP
"What the 2014 CDRH guidance package means for 510(k) strategy through 2017 — and the audit triggers to watch."
SR
Sandra L. Rasmussen
Chief Technology Officer, Cardiac & Vascular Group
Medtronic, Inc.
"Engineering the next 10 years of interventional care — the platforms, partnerships, and patient outcomes guiding our R&D pipeline."
Three-Day Program
Curated for operators, not attendees.
Every block is engineered for decision-grade content. Choose your track, follow it through, leave with answers.
Day 01 · Monday, Sept 29
Policy, Capital & Market Opening
- Registration & Executive Networking Breakfast
- Welcome Address — AdvaMed Chair & President
- Plenary: The 2015 Medtech Economic Outlook
- FDA Town Hall with CDRH Leadership
- Investor Forum — Public Company Pitches
Day 02 · Tuesday, Sept 30
Innovation, Digital & Clinical Evidence
- Clinical Innovator Roundtables
- Track A: Connected Devices & Cybersecurity
- Track B: Diagnostics & Personalized Medicine
- Industry Partnering — 25 Min One-on-Ones
- Networking Reception on the Exhibit Floor
Day 03 · Wed, Oct 1
Global Access & Closing Plenary
- Global Market Access: EU MDR Briefing
- BRIC & Emerging Markets Roundtable
- Workforce & Leadership in Medtech
- Closing Keynote: The Next Decade of Care
- Closing Reception — Chicago Cultural Center
2014 Premier Sponsors
The organizations underwriting the medtech conversation.
Medtronic
Johnson & Johnson
Abbott
Boston Scientific
Becton Dickinson
Stryker
Baxter International
Edwards Lifesciences
Zimmer Biomet
Hologic
Intuitive Surgical
St. Jude Medical
From Past Attendees
Why the industry's operators keep coming back.
Three perspectives from across the medtech value chain — manufacturer, investor, and clinical leader.
"There is no other week in the year where our entire commercial leadership is in one place, learning the same signals. AdvaMed is the rare conference that pays for itself in the first hour of structured meetings."
DC
David C. Calhoun
VP, Strategic Partnerships · Cardinal Health
"I schedule every thesis review in medtech around AdvaMed. The Investor Forum is the single most efficient three days I spend in the sector — period. We sourced our last two platform investments from introductions made on-site."
RH
Renee J. Hastings
Managing Director · Apax Partners Healthcare
"As a surgeon-innovator, the value of AdvaMed is the rare access to FDA reviewers, hospital purchasing decision-makers, and OEM R&D leaders in a single corridor. The closed-door clinical sessions are genuinely unmatched."
MP
Dr. Marisa P. Tanaka, MD
Chief of Interventional Radiology · UCSF Medical Center
Early registration closes August 15. After that, rates increase by $400.
Member, non-member, and academic rates available. Group discounts for teams of 5+. Exhibitor passes include access to all keynote sessions and the closing reception at the Chicago Cultural Center.